August 31, 2022 | Abata News Abata Therapeutics to Present at Upcoming September Investor Conferences July 7, 2022 | Abata News Abata Therapeutics to Participate in the Guggenheim I&I Spotlight Series – Treg-Based Therapies June 2, 2022 | Abata News Abata Therapeutics to Present at Upcoming Investor Conferences April 28, 2022 | Abata News Abata Therapeutics Appoints Sandy Lazzari as Chief People Officer April 6, 2022 | Abata News Abata Announces Formation of Advisory Board Comprised of Leading Industry Experts in Treg Biology, Cell Therapy and Corporate Development July 28, 2021 | Abata News Abata Therapeutics Strengthens Board of Directors June 23, 2021 | Abata News Abata Therapeutics Launches to Usher in New Era of Cell Therapy Using Targeted Regulatory T Cells to Treat Serious Autoimmune and Inflammatory Diseases
